Pharmacists play a vital role in oncology, enhancing patient care through medication management, education, and support for novel therapies.

Medically integrated dispensing is well-positioned to support value-based oncology care models and closer patient follow-up and monitoring, says Katherine Tobon, PharmD, BCOP.

Our quality initiative was performed in three stages (preintervention, intervention, and postintervention). Preintervention: retrospective baseline data collection from May to December 2019.

Adding a designated pharmacist to hematology-oncology teams reduced adverse drug reaction (ADR) rates by 62% (age-adjusted hazard ratio [AHR], 0.38). The pharmacist made 588 recommendations with a 95% ...

THE WOODLANDS, Texas--(BUSINESS WIRE)--Results from the second phase of the broad, collaborative MYLUNG Consortium TM research study in non-small cell lung cancer (NSCLC) were presented by The US ...

ASCO has worked to facilitate the improvement in quality oncology care via the development of the Quality Oncology Practice Initiative (QOPI). The extent to which the ASCO QOPI identifies areas in ...

As genomic medicine evolves, health systems are embedding pharmacogenomics into pharmacy operations, not only as a research function but as a clinical asset to personalize patient treatment and reduce ...

COA survey of independent community oncology practices shows insurer requirements delay treatment, override clinical ...

As cancer care becomes increasingly driven by complex, high-cost therapies, health systems are rethinking how tightly oncology and pharmacy are integrated. At Mount Sinai Medical Center in Miami Beach ...